Recombinant vaccines for COVID-19

SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycopro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711739/
https://www.ncbi.nlm.nih.gov/pubmed/33232211
http://dx.doi.org/10.1080/21645515.2020.1820808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711739/
https://www.ncbi.nlm.nih.gov/pubmed/33232211
http://dx.doi.org/10.1080/21645515.2020.1820808

Ejemplares similares